Patent · US Expired

2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines

US5712276A · kind A · utility

3Cited by
13References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 1995
Grant dateJan 27, 1998
Priority date
Expiry dateJun 6, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.